Robert I. Blum - 21 Dec 2022 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Signature
/s/ John Faurescu, attorney-in-fact for Mr. Blum
Issuer symbol
CYTK
Transactions as of
21 Dec 2022
Net transactions value
-$628,042
Form type
4
Filing time
11 Aug 2023, 16:18:13 UTC
Previous filing
05 Dec 2022
Next filing
03 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $96,500 +10,000 +2.5% $9.65 416,412 21 Dec 2022 Direct F3
transaction CYTK Common Stock Sale $439,240 -10,000 -2.4% $43.92 406,412 21 Dec 2022 Direct F3
transaction CYTK Common Stock Options Exercise $112,982 +11,708 +2.7% $9.65 453,125 11 Aug 2023 Direct F4
transaction CYTK Common Stock Sale $378,954 -11,708 -2.6% $32.37 441,417 11 Aug 2023 Direct F4
transaction CYTK Common Stock Options Exercise $6,304 +792 +0.18% $7.96* 442,209 11 Aug 2023 Direct F4
transaction CYTK Common Stock Sale $25,635 -792 -0.18% $32.37 441,417 11 Aug 2023 Direct F4
holding CYTK Common Stock 2,083 21 Dec 2022 by Trust 1 F1
holding CYTK Common Stock 2,083 21 Dec 2022 by Trust 2 F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -10,000 -6% $0.000000 155,691 21 Dec 2022 Common Stock 10,000 $9.65 Direct
transaction CYTK Incentive Stock Option (Right to Buy) Options Exercise $0 -11,708 -100% $0.000000* 0 11 Aug 2023 Common Stock 11,708 $9.65 Direct
transaction CYTK Incentive Stock Option (Right to Buy) Options Exercise $0 -792 -7.3% $0.000000 10,000 11 Aug 2023 Common Stock 792 $7.96 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares held by The Bridget Blum 2003 Irrevocable Trust.
F2 Shares held by The Brittany Blum 2003 Irrevocable Trust.
F3 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.
F4 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.